Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Cefuroxime axetil
Drug ID BADD_D00408
Description Not Available
Indications and Usage Not Available
Marketing Status Not Available
ATC Code Not Available
DrugBank ID Not Available
KEGG ID D00914
MeSH ID C040738
PubChem ID 5361467
TTD Drug ID Not Available
NDC Product Code 65862-700; 60429-656; 63629-9446; 63629-9448; 65862-699; 67877-216; 68071-2879; 68180-302; 65862-339; 51407-333; 60687-272; 68071-1637; 68180-303; 50090-2158; 67877-215; 68071-2958; 57237-059; 16714-400; 43063-584; 53002-2670; 57237-058; 63187-991; 65862-505; 43063-623; 43063-656; 53002-2750; 60429-657; 60687-283; 65862-698; 70518-2694; 61788-1000; 63629-9447; 16714-401; 50090-2157; 51407-334; 61919-747; 63629-9449; 82608-008; 43063-657; 72789-035
UNII Z49QDT0J8Z
Synonyms cefuroxime axetil | acetoxyethylcefuroxime | cefuroxime 1-acetoxyethyl ester | Ceftin | Zinnat | CCI 15641 | CCI-15641
Chemical Information
Molecular Formula C20H22N4O10S
CAS Registry Number 64544-07-6
SMILES CC(OC(=O)C)OC(=O)C1=C(CSC2N1C(=O)C2NC(=O)C(=NOC)C3=CC=CO3)COC(=O)N
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Sinusitis22.07.03.007; 11.01.13.005--
Somnolence19.02.05.003; 17.02.04.006--
Stevens-Johnson syndrome10.01.01.045; 23.03.01.007; 12.03.01.014; 11.07.01.005--
Stomatitis07.05.06.005--
Swollen tongue07.14.02.003; 23.04.01.014; 10.01.05.015--Not Available
Tachycardia02.03.02.007--Not Available
Thirst14.03.02.007; 08.01.09.021--Not Available
Thrombocytopenia01.08.01.002--Not Available
Toxic epidermal necrolysis11.07.01.006; 10.01.01.006; 23.03.01.008; 12.03.01.015--
Trismus17.01.03.004; 15.05.04.004--
Upper respiratory tract infection22.07.03.011; 11.01.13.009--
Urethral pain20.02.02.014--Not Available
Urine glucose false positive13.02.02.006--Not Available
Urticaria23.04.02.001; 10.01.06.001--
Vaginal discharge21.08.02.002--
Vaginal infection21.14.02.002; 11.01.10.002--
Vomiting07.01.07.003--
Vulvovaginal candidiasis11.03.03.005; 21.14.02.003--Not Available
Vulvovaginal discomfort21.08.02.005--Not Available
Urethral haemorrhage24.07.03.006; 20.07.01.003--Not Available
Muscle tightness15.05.03.007--Not Available
Musculoskeletal stiffness15.03.05.027--Not Available
Musculoskeletal discomfort15.03.04.001--Not Available
Haemorrhage24.07.01.002--Not Available
Vulvovaginal pruritus23.03.12.009; 21.08.02.004--Not Available
Blood alkaline phosphatase increased13.04.02.004--
Hepatic enzyme increased13.03.04.028--Not Available
Coombs test positive13.01.01.002--Not Available
Decreased appetite14.03.01.005; 08.01.09.028--
Renal impairment20.01.03.010--Not Available
The 3th Page    First    Pre   3 4    Next   Last    Total 4 Pages